![](/img/cover-not-exists.png)
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials
Soumerai, Jacob D., Ni, Ai, Xing, Guan, Huang, Julie, Furman, Richard R., Jones, Jeffrey, Sharman, Jeffrey P., Hallek, Michael, Adewoye, Adeboye H., Dubowy, Ronald, Dreiling, Lyndah, Zelenetz, AndrewLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2018.1540782
Date:
November, 2018
File:
PDF, 1.21 MB
english, 2018